Skip to main content

Table 2 Associations between clinical features and ESR

From: Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma

Characteristics

ESR+

ESR

P value

No. of cases (%)

Age (years)

  ≤ 60

37

77

0.849

  > 60

23

45

Sex

 Male

36

74

0.932

 Female

24

48

Stage

 III-IV

48

63

0.0002

 I-II

12

59

Myc

 Positive

28

32

0.006

 Negative

32

90

ECOG PS

  ≥ 2

20

10

< 0.0001

  < 2

40

112

LDH

 Over ULN

47

37

< 0.0001

 normal

13

85

ENI

  ≥ 2

21

24

0.024

  < 2

39

98

Bcl2

  ≥ 70%

30

56

0.603

  < 70%

30

66

IPI

 3–5

31

19

< 0.0001

 0–2

29

103

B symptoms

 Positive

43

42

< 0.0001

 Negative

17

80

COO (Hans)

 GCB

13

60

0.0004

 Non-GCB

47

62

DEL

 Positive

14

19

0.202

 Negative

46

103

  1. Abbreviations: COO: cell of origin; DEL: double expression lymphoma; ECOG PS: performance status of Eastern Cooperative Oncology Group; ENI: extranodal involvement; ESR: erythrocyte sedimentation rate; GCB: germinal-center B-cell type; IPI: International Prognostic Index; LDH: lactate dehydrogenase; ULN: upper limit of normal